← Leaderboards
Jochen Steppan
Johns Hopkins University
$1,512,807
Attributed
$1,512,807
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $654.2K · FY2019–24$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,512,807 · 2
By mechanism
K08$858,600 · 1
R56$654,207 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Larissa A Shimoda$18,862,133
- Roger A Johns$24,853,899
- John Huetsch$808,976
- Sheng Wu$3,673,062
- Lakshmi Santhanam$1,884,600
Others in their field
Other Emerging Leaders on “Pathway Interactions”
- April Brinkoetter · Hungry Heart Media, Inc.$59,802,265
- Kevin Urdahl · Seattle Children'S Hospital$47,227,116
- Urs Ochsner · Crestone, Inc.$38,569,476
- Mathangi Thiagarajan · Leidos Biomedical Research, Inc.$37,695,154
- Nader Fotouhi · Global Alliance For Tb Drug Development$28,468,137
- Jeffrey Glenn · Stanford University$26,017,226
Research focus
Pathway InteractionsRodent ModelExtracellular MatrixNovel Therapeutic InterventionReceptorResearch PersonnelDepositionExperimental StudyGenesMechanicsPreventRattusBiologyAnimalsCoronary FibrosisCrosslinkCellsElementsFoundationsCell BehaviorHeart FailureHypoxiaCollagenSignal Transduction
Grant awards (6)
Thrombospondin-1's role in heart failure with preserved ejection fraction (HFpEF)$654,207
R56 · FY2024 · HL · contact PI
The Therapeutic Role for LOLX2 in Pulmonary Hypertension$171,720
K08 · FY2023 · HL · contact PI
The Therapeutic Role for LOLX2 in Pulmonary Hypertension$171,720
K08 · FY2022 · HL · contact PI
The Therapeutic Role for LOLX2 in Pulmonary Hypertension$171,720
K08 · FY2021 · HL · contact PI
The Therapeutic Role for LOLX2 in Pulmonary Hypertension$171,720
K08 · FY2020 · HL · contact PI
The Therapeutic Role for LOLX2 in Pulmonary Hypertension$171,720
K08 · FY2019 · HL · contact PI